Texas HB4783 mandates a biennial report on opioid antagonist programs to reverse and prevent opioid overdoses.

Texas HB4783 requires the commission to prepare a biennial report evaluating the distribution of opioid antagonists in the state to reverse and prevent opioid overdoses. The report must include a needs assessment for the opioid antagonist program, establish a statewide saturation goal, describe funding, outline distribution strategies, list available purchase and distribution programs, and recommend improvements for high-risk populations. The report is due by October 1 of each even-numbered year and submitted to the governor, lieutenant governor, and speaker of the house of representatives.

Texas HB4783 mandates a biennial report on opioid antagonist programs to reverse and prevent opioid overdoses.

Texas HB4783 requires the commission to prepare a biennial report evaluating the distribution of opioid antagonists in the state to reverse and prevent opioid overdoses. The report must include a needs assessment for the opioid antagonist program, establish a statewide saturation goal, describe funding, outline distribution strategies, list available purchase and distribution programs, and recommend improvements for high-risk populations. The report is due by October 1 of each even-numbered year and submitted to the governor, lieutenant governor, and speaker of the house of representatives.